BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36898947)

  • 81. Evaluation and treatment of testicular cancer.
    Hesketh PJ
    Hosp Pract (Off Ed); 1987 Sep; 22(9A):87-90, 93-102. PubMed ID: 2484998
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis.
    Thomas LJ; Brooks MA; Stephenson AJ
    Urol Clin North Am; 2019 Aug; 46(3):315-331. PubMed ID: 31277727
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes.
    Rice KR; Magers MJ; Beck SD; Cary KC; Einhorn LH; Ulbright TM; Foster RS
    J Urol; 2014 Nov; 192(5):1403-9. PubMed ID: 24952240
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Infertility with Testicular Cancer.
    Ostrowski KA; Walsh TJ
    Urol Clin North Am; 2015 Aug; 42(3):409-20. PubMed ID: 26216827
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
    Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
    Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The case for relevant staging of germ cell tumors.
    Logothetis CJ
    Cancer; 1990 Feb; 65(3 Suppl):709-17. PubMed ID: 2154316
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Late relapse of testicular germ cell tumors.
    Carver BS; Motzer RJ; Kondagunta GV; Sogani PG; Sheinfeld J
    Urol Oncol; 2005; 23(6):441-5. PubMed ID: 16301125
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nonseminomatous germ cell tumor of the testicle: does extensive staging of the primary tumor predict the likelihood of metastatic disease?
    Rodriguez PN; Hafez GR; Messing EM
    J Urol; 1986 Sep; 136(3):604-8. PubMed ID: 3016346
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol.
    Honeyball F; Murali-Ganesh R; Hruby G; Grimison P
    Intern Med J; 2015 Oct; 45(10):1081-4. PubMed ID: 26429219
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multifocality in testicular germ cell tumors.
    Ehrlich Y; Konichezky M; Yossepowitch O; Baniel J
    J Urol; 2009 Mar; 181(3):1114-9; discussion 1119-20. PubMed ID: 19150559
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Management of germ cell tumors of the adult testis at the Memorial Sloan Kettering Cancer Center.
    Whitmore WF; Bosl G
    Acta Urol Belg; 1985; 53(2):341-61. PubMed ID: 2990181
    [No Abstract]   [Full Text] [Related]  

  • 97. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
    Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
    Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Pathogenesis, diagnosis and therapy of testicular tumors].
    Weissbach I; Bussar-Maatz R
    Urologe A; 1996 Mar; 35(2):163-72. PubMed ID: 8650851
    [No Abstract]   [Full Text] [Related]  

  • 99. Management of Stage I Nonseminomatous Germ Cell Tumors.
    Kovac E; Stephenson AJ
    Urol Clin North Am; 2015 Aug; 42(3):299-310. PubMed ID: 26216817
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.